| SCHRODER ISF ASIAN OPPORTUNITIES C ACC SGD | RVI ASIA EX-JAPÓN | 43,50% | 36,41% | 14,17% | · |
| INVESCO NASDAQ BIOTECH UCITS ETF ACC | BIOTECNOLOGÍA | 43,49% | 32,45% | 30,41% | 99,99% |
| ISHARES ASIA PACIFIC DIVIDEND UCITS ETF USD (DIST) | RVI ASIA | 43,47% | 37,04% | 22,72% | 21,64% |
| UBS MSCI EM SOCIALLY RESPONSIBLE UCITS ETF USD DIS | RVI EMERGENTES | 43,46% | 44,64% | 18,47% | · |
| AMSELECT ROBECO GLOBAL EQUITY EMERGING PRIVILEGE CAP | RVI EMERGENTES | 43,45% | 54,09% | · | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS A-ACC-USD | RVI ASIA EX-JAPÓN | 43,45% | 39,51% | 8,00% | 107,44% |
| MATTHEWS ASIA FUNDS-CHINA SMALL COMPANIES I CAP USD | RVI CHINA | 43,45% | 15,52% | -18,79% | · |
| SCHRODER ISF GLOBAL EQUITY YIELD A MDIS AUD (HEDGED) | RVI GLOBAL VALOR | 43,45% | 23,49% | 15,53% | · |
| AMSELECT ROBECO GLOBAL EQUITY EMERGING I CAP | RVI EMERGENTES | 43,44% | 54,08% | · | · |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES I2 EUR | RVI JAPÓN SMALL/MID CAP | 43,44% | 61,07% | 32,64% | · |
| GESIURIS MULTIGESTION / EMERGENTES GLOBAL | MIXTO FLEXIBLE | 43,44% | 24,55% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO IO GBP CAP | RVI EMERGENTES | 43,44% | 51,38% | 15,32% | 143,91% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO I SEK CAP | RVI EMERGENTES | 43,44% | 48,31% | 11,72% | · |
| XTRACKERS MSCI THAILAND UCITS ETF 1C | RVI ASIA EX-JAPÓN | 43,44% | 10,49% | 18,49% | 57,37% |
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI S USD ACC | RVI EMERGENTES | 43,42% | 68,77% | 43,68% | · |
| SCHRODER ISF SUSTAINABLE EMERGING MARKETS SYNERGY C ACC GBP | RVI EMERGENTES | 43,42% | 50,77% | · | · |
| FIDELITY FUNDS-EMERGING EUROPE, MIDDLE EAST AND AFRICA Y-ACC-USD | RVI EMERGENTES | 43,41% | 76,79% | 3,42% | 61,05% |
| HSBC GIF CHINA A-SHARES EQUITY AC USD | RVI CHINA | 43,41% | 27,68% | 2,43% | · |
| ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF USD (ACC) | BIOTECNOLOGÍA | 43,41% | 32,42% | 28,02% | · |
| NEUBERGER BERMAN EMERGING MARKETS EQUITY CAD I DIS | RVI EMERGENTES | 43,41% | 62,10% | 23,83% | · |
